All articles by Ross Law

Astria Therapeutics taps Ypsomed’s autoinjector for hereditary angioedema drug delivery

Astria Therapeutics has selected Ypsomed’s Ypsomate autoinjector as its partner for the administration of STAR-0215 for the treatment of hereditary…
Leap Consulting launches practice to assist labs with FDA’s LDT ruling

US-based Leap Consulting Group has launched a practice aimed at guiding Clinical Laboratory Improvement Amendments-certified labs (CLIA) in adhering to…
AAIC 2024: MCI patient reflects on Leqembi trial experience

During a session at the 2024 Alzheimer’s Association International Conference (AAIC), which concludes today, Ralph Carmona shared his experience of…
Magazine: Left in limbo: when pharma halts rare disease research

Gene therapy research is expensive. Biotechs invest millions of dollars in early research to develop therapies for conditions that might…
Alzheimer’s: drug delivery and the blood brain barrier conundrum

With the 2024 edition of the Alzheimer's Association International Conference (AAIC) underway in Philadelphia until 1 August, research into approaches…

Boehringer Ingelheim plans sustainability work for the long term

Frameworks for environmental, social, and governance (ESG) reporting across sectors have long been focused on environmental sustainability, with plans that…
2seventy bio completes $40m haemophilia A program deal with Novo Nordisk

US-based 2seventy bio has completed an asset purchase agreement (APA) to divest its haemophilia A candidate to Novo Nordisk. 2seventy…
Ability Biologics closes extended $18m seed funding round

Cancer-focused biotech Ability Biologics has announced the close of an $18m seed funding extension round. The Canadian biotech uses its…
Study finds most patients in TARGET-NASH registry meet revised MASLD criteria

Analytics firm Target RWE has published its findings that 99% of participants in TARGET-NASH, a research registry of patients with…
Tacalyx extends seed funding round to raise over €14m

Cancer-focused biotech Tacalyx has extended its seed financing round to raise over €14m ($15.03m). The German biotech has established a…